Bristol-Myers Squibb $2PR (BMYMP) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 14 85 sessions, March 18, 2025 to March 18, 2026
- Largest daily move
- -18.7% close of March 13, 2026
- 1-year change
- -33.3% closing prices, March 18, 2025 to March 18, 2026
- 1-month change
- -30.2% closing prices, February 13, 2026 to March 18, 2026
Company Description
BMYMP declined 33.3% in the 12 months to March 18, 2026. The last closing price was $700.00.
For FY2025, Bristol-Myers Squibb $2PR reported revenue of $48.2B with net income of $7.1B and diluted earnings per share of $3.46. The company operates at a net profit margin of 14.6%.
This page collects what Stock Titan holds for BMYMP, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Bristol-Myers Squibb $2PR (BMYMP) closed at $700.00 on March 18, 2026. In the 12 months to March 18, 2026, the price lost 33.3%.
BMYMP Metrics & Rankings
Price returns through March 18, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Bristol-Myers Squibb $2PR has filed 10 recent SEC filings, including 6 Form 4, 2 Form 8-K, 1 Form 10-Q, 1 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BMYMP SEC filings →
Financial Highlights
Bristol-Myers Squibb $2PR generated $48.2B in revenue in FY2025, retaining a 71.1% gross margin, and net income was $7.1B, reflecting a 14.6% net profit margin. Diluted earnings per share stood at $3.46. The company generated $14.2B in operating cash flow. The current ratio was 1.26, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Bristol-Myers Squibb $2PR (BMYMP) currently stands at 49 shares, representing 1.4% of the float. Since November 2025, short interest has increased by 308.3%.
Days to Cover History
Days to cover for Bristol-Myers Squibb $2PR (BMYMP) currently stands at 49.0 days, up 1799.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 1125%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.